CSF fibrinogen predicts longitudinal Tau accumulation in cognitively unimpaired older adults

Aug 12

Written by Fanny Elahi

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer’s Disease from Phase 3 and Phase 2 Trials

ABCA7-80 moderates vascular stiffness–p-tau217 association in older African Americans